HaemoCer™ PLUS

Haemostasis and Adhesion Prevention Barrier ideal to nature HaemoCer™ PLUS Absorbable Polysaccharide Haemostat (APH) is a proprietary patent pending technology based on BioCers Polysacharide Ultra-hydrophilic Resorbable Engineering (PURE) process. HaemoCer™ PLUS APH incorporates a sophisticated, plant-based polymer crosslinking that creates ultra-hydrophilic, biocompatible particles. Once in contact with blood, HaemoCer™ PLUS enhances the natural clotting cascade by rapidly dehydrating the blood and accelerating the concentration of platelets, red blood cells and coagulation proteins at the bleeding site. The second mode of action of HaemoCer™ PLUS is the formation of a robust gelled matrix that adheres to the bleeding site and forms a mechanical barrier to prevent further bleeding. HaemoCer™ PLUS is rapidly resorbed by amylase within a few days without leaving any residues behind, depending on the amount of used material and the place of application. HaemoCer™ PLUS contains no animal nor human components and is rapidly resorbed and degraded by amylase. HaemoCer™ PLUS is indicated for use in surgical procedures or injuries as an adjunct haemostat, when control of bleeding from capillary, venous, or arteriolar vessels by pressure, ligature and other conventional means is either ineffective or impractical. HaemoCer™ PLUS with its patent pending technology is manufactured in Germany and available as well as approved nearly worldwide.